Triall is attending BIO-Europe spring on March 20-22 in Basel, Switzerland. Next to our on-site attendance, Triall co-founder Raymond van der Waal will be hosting a digital presentation titled "Unpacking EMA guidance on decentralised trials: implications for conventional and emerging technologies".
The event brings together over 2,800 executives from biotech, Pharma, and finance organisations, and is expecting to facilitate more than 15,000 one-on-one meetings.
About BIO-Europe Spring
BIO-Europe Spring is a premier European networking event for the global Life Sciences community. The event caters to the needs of the entire drug development value chain by providing start-up and innovator educational programmes, industry trends and outlooks from KOLs, company pitches, professional partnering meetings as well as various networking opportunities.
